Dr Limited Stock Current Valuation
| 301177 Stock | 25.79 0.14 0.54% |
Valuation analysis of DR Limited helps investors to measure DR's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of December 16, 2024, Cash is expected to decline to about 216.5 M. The current year's Change In Cash is expected to grow to about (279.9 M). Fundamental drivers impacting DR's valuation include:
Price Book 1.6503 | Enterprise Value 5.7 B | Enterprise Value Ebitda 94.0673 | Price Sales 6.7182 | Trailing PE 864.3334 |
Overvalued
Today
Please note that DR's price fluctuation is not too volatile at this time. Calculation of the real value of DR Limited is based on 3 months time horizon. Increasing DR's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since DR is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DR Stock. However, DR's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.79 | Real 21.52 | Hype 25.54 |
The real value of DR Stock, also known as its intrinsic value, is the underlying worth of DR Limited Company, which is reflected in its stock price. It is based on DR's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of DR's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of DR Limited helps investors to forecast how DR stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DR more accurately as focusing exclusively on DR's fundamentals will not take into account other important factors: DR Limited Company Current Valuation Analysis
DR's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DR Current Valuation | 5.67 B |
Most of DR's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DR Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DR Limited has a Current Valuation of 5.67 B. This is much higher than that of the Textiles, Apparel & Luxury Goods sector and significantly higher than that of the Consumer Discretionary industry. The current valuation for all China stocks is notably lower than that of the firm.
DR Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DR's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DR could also be used in its relative valuation, which is a method of valuing DR by comparing valuation metrics of similar companies.DR is currently under evaluation in current valuation category among its peers.
DR Fundamentals
| Return On Equity | 0.0024 | ||||
| Return On Asset | -0.0094 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 5.67 B | ||||
| Shares Outstanding | 400.01 M | ||||
| Shares Owned By Insiders | 91.19 % | ||||
| Shares Owned By Institutions | 0.29 % | ||||
| Price To Book | 1.65 X | ||||
| Price To Sales | 6.72 X | ||||
| Revenue | 2.18 B | ||||
| Gross Profit | 2.57 B | ||||
| EBITDA | (105.4 M) | ||||
| Net Income | 68.96 M | ||||
| Total Debt | 390 M | ||||
| Book Value Per Share | 15.71 X | ||||
| Cash Flow From Operations | 36.97 M | ||||
| Earnings Per Share | 0.03 X | ||||
| Target Price | 20.74 | ||||
| Number Of Employees | 3.2 K | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 10.37 B | ||||
| Total Asset | 7.53 B | ||||
| Retained Earnings | 1.41 B | ||||
| Working Capital | 5.34 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 7.53 B | ||||
| Last Dividend Paid | 0.5 |
About DR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DR Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DR Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DR Stock
DR financial ratios help investors to determine whether DR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DR with respect to the benefits of owning DR security.